209 related articles for article (PubMed ID: 26907871)
1. [Soft tissue sarcomas and gastrointestinal stromal tumors].
Reichardt P
Internist (Berl); 2016 Mar; 57(3):245-56. PubMed ID: 26907871
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of soft tissue sarcomas including GIST - Update 2021].
Reichardt P; Pink D
Dtsch Med Wochenschr; 2021 Feb; 146(3):157-161. PubMed ID: 33513648
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of cediranib in patients with advanced gastrointestinal stromal tumors or soft-tissue sarcoma.
Judson I; Scurr M; Gardner K; Barquin E; Marotti M; Collins B; Young H; Jürgensmeier JM; Leahy M
Clin Cancer Res; 2014 Jul; 20(13):3603-12. PubMed ID: 24714778
[TBL] [Abstract][Full Text] [Related]
4. [Systemic therapy of soft tissue sarcomas].
Pink D; Bertz-Lepel J; Reichardt P
Pathologe; 2011 Feb; 32(1):65-71. PubMed ID: 21053001
[TBL] [Abstract][Full Text] [Related]
5. [The importance of mutational status in prognosis and therapy of GIST].
Comandone A; Boglione A
Recenti Prog Med; 2015 Jan; 106(1):17-22. PubMed ID: 25621775
[TBL] [Abstract][Full Text] [Related]
6. Histology-Specific Uses of Tyrosine Kinase Inhibitors in Non-gastrointestinal Stromal Tumor Sarcomas.
Sethi TK; Keedy VL
Curr Treat Options Oncol; 2016 Feb; 17(2):11. PubMed ID: 26931561
[TBL] [Abstract][Full Text] [Related]
7. Tyrosine kinase inhibitors in treating soft tissue sarcomas: sunitinib in non-GIST sarcomas.
Homet Moreno B; Garralda Cabanas E; Hitt R
Clin Transl Oncol; 2010 Jul; 12(7):468-72. PubMed ID: 20615823
[TBL] [Abstract][Full Text] [Related]
8. [Medical treatment of soft tissue sarcomas based on the histological subtype].
Pápai Z
Magy Onkol; 2014 Mar; 58(1):53-8. PubMed ID: 24712007
[TBL] [Abstract][Full Text] [Related]
9. Current Molecular Targeted Therapies for Bone and Soft Tissue Sarcomas.
Nakano K; Takahashi S
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29510588
[TBL] [Abstract][Full Text] [Related]
10. Systemic treatment options for patients with refractory adult-type sarcoma beyond anthracyclines.
Hartmann JT
Anticancer Drugs; 2007 Mar; 18(3):245-54. PubMed ID: 17264755
[TBL] [Abstract][Full Text] [Related]
11. Time to Definitive Failure to the First Tyrosine Kinase Inhibitor in Localized GI Stromal Tumors Treated With Imatinib As an Adjuvant: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomized Trial in Collaboration With the Australasian Gastro-Intestinal Trials Group, UNICANCER, French Sarcoma Group, Italian Sarcoma Group, and Spanish Group for Research on Sarcomas.
Casali PG; Le Cesne A; Poveda Velasco A; Kotasek D; Rutkowski P; Hohenberger P; Fumagalli E; Judson IR; Italiano A; Gelderblom H; Adenis A; Hartmann JT; Duffaud F; Goldstein D; Broto JM; Gronchi A; Dei Tos AP; Marréaud S; van der Graaf WT; Zalcberg JR; Litière S; Blay JY
J Clin Oncol; 2015 Dec; 33(36):4276-83. PubMed ID: 26573069
[TBL] [Abstract][Full Text] [Related]
12. [Novel molecular-targeted agents for GIST(Regorafenib etc.)].
Naito Y; Doi T
Gan To Kagaku Ryoho; 2013 Jan; 40(1):15-8. PubMed ID: 23306914
[TBL] [Abstract][Full Text] [Related]
13. Brostallicin, an agent with potential activity in metastatic soft tissue sarcoma: a phase II study from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
Leahy M; Ray-Coquard I; Verweij J; Le Cesne A; Duffaud F; Hogendoorn PC; Fowst C; de Balincourt C; di Paola ED; van Glabbeke M; Judson I; Blay JY;
Eur J Cancer; 2007 Jan; 43(2):308-15. PubMed ID: 17095209
[TBL] [Abstract][Full Text] [Related]
14. GEIS guidelines for gastrointestinal sarcomas (GIST).
Poveda A; García Del Muro X; López-Guerrero JA; Cubedo R; Martínez V; Romero I; Serrano C; Valverde C; Martín-Broto J;
Cancer Treat Rev; 2017 Apr; 55():107-119. PubMed ID: 28351781
[TBL] [Abstract][Full Text] [Related]
15. [Surgical news of soft tissue sarcomas, fibromatosis and GIST].
Bonvalot S; Rimareix F; Bouzaiene H
Bull Cancer; 2010 Jun; 97(6):645-56. PubMed ID: 20547479
[TBL] [Abstract][Full Text] [Related]
16. Surgical Management of Sarcoma Metastatic to Liver.
Ecker BL; Maki RG; Cavnar MJ; DeMatteo RP
Surg Oncol Clin N Am; 2021 Jan; 30(1):57-67. PubMed ID: 33220809
[TBL] [Abstract][Full Text] [Related]
17. The outcome of targeted therapy in advanced gastrointestinal stromal tumors (GIST) with non-exon 11 KIT mutations.
Osuch C; Rutkowski P; Brzuszkiewicz K; Bylina E; Limon J; Siedlecki JA
Pol Przegl Chir; 2014 Jul; 86(7):325-32. PubMed ID: 25222580
[TBL] [Abstract][Full Text] [Related]
18. Potential combination chemotherapy approaches for advanced adult-type soft-tissue sarcoma.
Kopp HG; Patel S; Brücher B; Hartmann JT
Am J Clin Dermatol; 2008; 9(4):207-17. PubMed ID: 18572972
[TBL] [Abstract][Full Text] [Related]
19. S0502: A SWOG Phase III Randomized Study of Imatinib, With or Without Bevacizumab, in Patients With Untreated Metastatic or Unresectable Gastrointestinal Stromal Tumors.
Blanke CD; Rankin C; Corless C; Eary JF; Mulder K; Okuno SH; George S; Heinrich M
Oncologist; 2015 Dec; 20(12):1353-4. PubMed ID: 26576593
[TBL] [Abstract][Full Text] [Related]
20. Current management of gastrointestinal stromal tumors--a comprehensive review.
Lai EC; Lau SH; Lau WY
Int J Surg; 2012; 10(7):334-40. PubMed ID: 22633986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
